Meihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
Meihua International Medical Technologies Co., (MHUA), a manufacturer of disposable medical devices, has regained compliance with Nasdaq's minimum bid price requirement. The company received a notification letter on October 3, 2024, confirming that it has met the $1.00 minimum bid price for 21 consecutive business days from September 4 to October 2, 2024.
This development resolves the compliance issue raised on April 2, 2024, when MHUA was notified of failing to maintain the required minimum bid price. The matter is now closed, and MHUA has successfully addressed the concerns related to Nasdaq Listing Rule 5450(a)(1).
Meihua International Medical Technologies Co., (MHUA), un produttore di dispositivi medici usa e getta, ha riottenuto la conformità con il requisito del prezzo minimo di offerta di Nasdaq. L'azienda ha ricevuto una lettera di notifica il 3 ottobre 2024, confermando di aver soddisfatto il prezzo minimo di offerta di $1.00 per 21 giorni lavorativi consecutivi dal 4 settembre al 2 ottobre 2024.
Questo sviluppo risolve la questione di conformità sollevata il 2 aprile 2024, quando MHUA è stata notificata di aver mancato di mantenere il prezzo minimo di offerta richiesto. La questione è ora chiusa e MHUA ha affrontato con successo le preoccupazioni relative alla Regola di quotazione di Nasdaq 5450(a)(1).
Meihua International Medical Technologies Co., (MHUA), un fabricante de dispositivos médicos desechables, ha recuperado la conformidad con el requisito del precio mínimo de oferta de Nasdaq. La compañía recibió una carta de notificación el 3 de octubre de 2024, confirmando que ha cumplido con el precio mínimo de oferta de $1.00 durante 21 días hábiles consecutivos desde el 4 de septiembre hasta el 2 de octubre de 2024.
Este desarrollo resuelve el problema de conformidad planteado el 2 de abril de 2024, cuando se notificó a MHUA que no había mantenido el precio mínimo de oferta requerido. El asunto está ahora cerrado, y MHUA ha abordado con éxito las preocupaciones relacionadas con la Regla de cotización de Nasdaq 5450(a)(1).
Meihua International Medical Technologies Co., (MHUA), 일회용 의료기기 제조업체가 Nasdaq의 최소 입찰 가격 요구 사항을 재보장했습니다. 이 회사는 2024년 10월 3일에 통지 서한을 받았으며, 2024년 9월 4일부터 10월 2일까지 21일 연속으로 $1.00의 최소 입찰 가격을 충족했음을 확인했습니다.
이번 발전은 2024년 4월 2일 MHUA가 요구되는 최소 입찰 가격을 유지하지 못한 사실을 통보받았을 때 제기된 준수 문제를 해결합니다. 해당 문제는 이제 종료되었으며, MHUA는 Nasdaq 상장 규칙 5450(a)(1)과 관련된 우려 사항을 성공적으로 해결했습니다.
Meihua International Medical Technologies Co., (MHUA), un fabricant de dispositifs médicaux jetables, a rétabli la conformité avec l'exigence de prix d'offre minimum de Nasdaq. La société a reçu une lettre de notification le 3 octobre 2024, confirmant qu'elle a respecté le prix d'offre minimum de 1,00 $ pendant 21 jours ouvrables consécutifs, du 4 septembre au 2 octobre 2024.
Ce développement résout le problème de conformité soulevé le 2 avril 2024, lorsque MHUA a été informée qu'elle n'avait pas maintenu le prix d'offre minimum requis. L'affaire est maintenant close, et MHUA a réussi à résoudre les préoccupations liées à la règle de cotation Nasdaq 5450(a)(1).
Meihua International Medical Technologies Co., (MHUA), ein Hersteller von Einweg-Medizinprodukten, hat die Konformität mit den Mindestangebotspreisanforderungen von Nasdaq wiedererlangt. Das Unternehmen erhielt am 3. Oktober 2024 ein Benachrichtigungsschreiben, in dem bestätigt wurde, dass es den Mindestangebotspreis von $1.00 für 21 aufeinanderfolgende Handelstage vom 4. September bis zum 2. Oktober 2024 eingehalten hat.
Diese Entwicklung löst das Compliance-Problem, das am 2. April 2024 angesprochen wurde, als MHUA darüber informiert wurde, dass es die erforderlichen Mindestangebotspreis nicht aufrechterhalten konnte. Die Angelegenheit ist nun geschlossen, und MHUA hat die Bedenken im Zusammenhang mit der Nasdaq-Listing-Regel 5450(a)(1) erfolgreich angesprochen.
- Regained compliance with Nasdaq's minimum bid price requirement
- Stock price maintained above $1.00 for 21 consecutive business days
- Resolved potential delisting risk
- None.
YANGZHOU,
As previously reported, the Company was notified on April 2, 2024, that its ordinary shares failed to maintain a minimum bid price of
Since then, Nasdaq has determined that for the last 21 consecutive business days, from September 4, 2024 to October 2, 2024, the closing bid price of the Company's Ordinary Shares has been at
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. is a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in
For more information, please visit www.meihuamed.com.
Follow us on Webull: https://www.webull.com/quote/nasdaq-mhua.
For investor and media inquiries, please contact:
IR Department
Email: secretary@meihuamed.com
Tel: +86-0514-89800199
Christensen
Yang Song
Email: yang.song@christensencomms.com
Tel: +86-010-59001548
View original content:https://www.prnewswire.com/news-releases/meihua-international-medical-technologies-co-ltd-regains-compliance-with-nasdaq-minimum-bid-price-requirement-302268608.html
SOURCE Meihua International Medical Technologies Co., Ltd.
FAQ
What was the compliance issue MHUA faced with Nasdaq?
When did MHUA regain compliance with Nasdaq's minimum bid price requirement?
What is the stock symbol for Meihua International Medical Technologies Co., ?